Publication | Closed Access
Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
55
Citations
24
References
2008
Year
OncologyPh-positive Cml LivingClinical TherapeuticPharmacologyPharmacotherapyMedicineNovel TherapyDrug DiscoveryTherapeutic Choices
| Year | Citations | |
|---|---|---|
Page 1
Page 1